Hematopoietic Cell Transplantation With Post-transplantation Cyclophosphamide in MDS

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

December 16, 2021

Study Completion Date

December 16, 2021

Conditions

Myelodysplastic Syndromes

Interventions

DRUG

Cyclophosphamide

Cyclophosphamide 50 mg/kg/day i.v. daily on days 3 and 4 of hematopoietic cell transplantation

Trial Locations (1)

Asan Medical Center, University of Ulsan College of Medicine, Seoul